Bruce A C Cree

Bruce A C Cree

UNVERIFIED PROFILE

Are you Bruce A C Cree?   Register this Author

Register author
Bruce A C Cree

Bruce A C Cree

Publications by authors named "Bruce A C Cree"

Are you Bruce A C Cree?   Register this Author

94Publications

2017Reads

10Profile Views

Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MS.

Neurol Neuroimmunol Neuroinflamm 2019 Nov 11;6(6). Epub 2019 Sep 11.

From the Central Texas Neurology Consultants (E.J.F.), Round Rock, TX; Icahn School of Medicine at Mount Sinai (F.D.L.), New York, NY; McGovern Medical School (J.S.W.), The University of Texas Health Science Center at Houston (UTHealth), TX; Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic Foundation, OH; Oxford PharmaGenesis Ltd (I.M.W.), UK; Novartis Pharmaceuticals Corporation (X.M., M.Z., S.K.), East Hanover, NJ; and The University of California, San Francisco (UCSF); Weill Institute for Neurosciences, Department of Neurology (B.A.C.C.), San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000614DOI Listing
November 2019

Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"

Ann Neurol 2019 Sep 12;86(3):472-473. Epub 2019 Jul 12.

UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.25536DOI Listing
September 2019

Telomere length is associated with disability progression in multiple sclerosis.

Ann Neurol 2019 Sep 4. Epub 2019 Sep 4.

UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.25592DOI Listing
September 2019

Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm.

Curr Opin Neurol 2019 Jun;32(3):365-377

Department of Neurology, Medical Faculty and Center for Neurology and Neuropsychiatry, LVR Klinikum, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000700DOI Listing
June 2019

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis.

J Neurol 2019 May 28;266(5):1182-1193. Epub 2019 Feb 28.

Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-019-09248-6
Publisher Site
http://dx.doi.org/10.1007/s00415-019-09248-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469695PMC
May 2019

pRNFL as a marker of disability worsening in the medium/long term in patients with MS.

Neurol Neuroimmunol Neuroinflamm 2019 Mar 21;6(2):e533. Epub 2018 Dec 21.

Department of Neurology (C.C., M.D., V.D., D.B., S.L.H., B.A.C.C., J.M.G., A.J.G.), UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA; and Department of Neurology (B.N.), Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340330PMC
March 2019

Rituximab in neurological disease: principles, evidence and practice.

Pract Neurol 2019 Feb 29;19(1):5-20. Epub 2018 Nov 29.

Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/practneurol-2018-001899DOI Listing
February 2019

Disease-modifying therapies alter gut microbial composition in MS.

Neurol Neuroimmunol Neuroinflamm 2019 Jan 26;6(1):e517. Epub 2018 Oct 26.

Department of Neurology (I.K.S., A.N., R.B., Y.B.), Department of Neuroscience (Y.Z., P.C.), and Department of Genetics & Genomic Sciences, Icahn Institute for Genomics & Multiscale Biology (J.C.C.), Icahn School of Medicine at Mount Sinai; Department of Neurology (E.C., E.C.-H., S.S., B.A.C.C., S.E.B.), Weill Institute for Neurosciences, University of California, San Francisco; E.C. is now with Universities Space Research Association, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA; Department of Pediatrics (J.D., R.K.), Department of Computer Science & Engineering (R.K.), and Center for Microbiome Innovation (R.K.), University of California, San Diego; and Neuroscience Initiative (P.C.), Advanced Research Science Center at the Graduate Center of the City University of New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000517DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278850PMC
January 2019

Treatment retention on fingolimod compared with injectable multiple sclerosis therapies in African-American patients: A subgroup analysis of a randomized phase 4 study.

Mult Scler Relat Disord 2018 Oct 11;25:50-56. Epub 2018 Jul 11.

UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.07.014DOI Listing
October 2018

Multiple Sclerosis Therapy: Are We Ready for a One-Size-Fits-All Approach?

Authors:
Bruce A C Cree

J Neuroophthalmol 2018 06;38(2):258-262

Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNO.0000000000000640DOI Listing
June 2018

Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.

Neurol Neuroimmunol Neuroinflamm 2018 May 19;5(3):e453. Epub 2018 Mar 19.

Department of Neurology, Weill Institute for the Neurosciences, University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858951PMC
May 2018

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Neurology 2018 04;90(17):777-788

From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; Department of Neurology (G.S.D.), Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis, MO; Department of Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Department of Neurology (A.R.), Mayo Clinic, Rochester, MN; UCSF Weill Institute for Neurosciences, Department of Neurology (B.A.C.C.), University of California, San Francisco; Department of Neurology (G.S.G.), Kansas University Medical Center, Kansas City; Department of Neurology (M.H.), School of Medicine, University of Louisville, KY; Consortium of Multiple Sclerosis Centers (J.H.), Hackensack, NJ; Department of Neuroscience (J.P.H.), St. Luke's University Health Network, Bethlehem, PA; Department of Neurology (D.E.J.), University of Virginia, Charlottesville; Consortium of Multiple Sclerosis Centers (R.L.), Hackensack, NJ; Department of Neurology (R.L.), School of Medicine, Wayne State University, Detroit, MI; Department of Neurology (D.P.), Keck School of Medicine, University of Southern California; Neurology Department (S.P.), Southern California Permanente Medical Group, Kaiser, Los Angeles; National Multiple Sclerosis Society (C.S.), Arlington, VA; National Multiple Sclerosis Society (R.S.), New York, NY; Santa Fe (J.S.), NM; Heart Rhythm Society (T.S.D.G.), Washington, DC; American Academy of Neurology (S.A.M.), Minneapolis, MN; and Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences, Cumming School of Medicine (T.P.), University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005347DOI Listing
April 2018

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Neurology 2018 04;90(17):789-800

From the Department of Neurology (A.R.-G.), Cleveland Clinic, OH; Department of Neurology (G.S.D.), Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis, MO; Department of Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Department of Neurology (A.R.), Mayo Clinic, Rochester, MN; UCSF Weill Institute for Neurosciences, Department of Neurology (B.A.C.C.), University of California, San Francisco; Department of Neurology (G.S.G.), Kansas University Medical Center, Kansas City; Department of Neurology, School of Medicine (M.H.), University of Louisville, KY; Consortium of Multiple Sclerosis Centers (J.H.), Hackensack, NJ; Department of Neuroscience (J.P.H.), St. Luke's University Health Network, Bethlehem, PA; Department of Neurology (D.E.J.), University of Virginia, Charlottesville; Consortium of Multiple Sclerosis Centers (R.L.), Hackensack, NJ; Department of Neurology, School of Medicine (R.L.), Wayne State University, Detroit, MI; Department of Neurology, Keck School of Medicine (D.P.), University of Southern California, Los Angeles; Neurology Department (S.P.), Southern California Permanente Medical Group, Kaiser, Los Angeles; National Multiple Sclerosis Society (C.S.), Arlington, VA; National Multiple Sclerosis Society (R.S.), New York, NY; Santa Fe (J.S.), NM; Heart Rhythm Society (T.S.D.G.), Washington, DC; American Academy of Neurology (S.A.M.), Minneapolis, MN; and Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences, Cumming School of Medicine (T.P.), University of Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://www.neurology.org/lookup/doi/10.1212/WNL.000000000000
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000005345DOI Listing
April 2018

Ovarian aging is associated with gray matter volume and disability in women with MS.

Neurology 2018 01 22;90(3):e254-e260. Epub 2017 Dec 22.

From the Departments of Neurology (J.S.G., R.G.H., B.A.C.C., E.W., A.Z., S.L.H., J.R.O.), Pharmacology (R.M.G.), Obstetrics, Gynecology and Reproductive Sciences (M.I.C.), and Epidemiology and Biostatistics (P.B.), University of California, San Francisco; and Women and Infants Hospital and the Alpert Medical School at Brown University (G.L.-M.), Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772165PMC
January 2018

The Gut Microbiome in Neuromyelitis Optica.

Neurotherapeutics 2018 01;15(1):92-101

Department of Neurology, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-017-0594-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794705PMC
January 2018

Ocrelizumab and Other CD20 B-Cell-Depleting Therapies in Multiple Sclerosis.

Neurotherapeutics 2017 Oct;14(4):835-841

Multiple Sclerosis Center, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s13311-017-0557-4
Publisher Site
http://dx.doi.org/10.1007/s13311-017-0557-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722762PMC
October 2017

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.

Neurology 2017 Oct 15;89(15):1584-1593. Epub 2017 Sep 15.

From Biogen (T.P., K.K.M., G.K., D.M., K.E., M.S., I.N., Y.C., Q.D., P.-R.H., D.A.), Cambridge, MA; Ashfield Healthcare Communications (A.A.), Middletown, CT; Hôpital Civil (J.D.S.), Strasbourg, France; Mellen Center for Multiple Sclerosis (R.F.), Cleveland Clinic, OH; St. Josef Hospital (R.G.), Ruhr University, Bochum, Germany; Piedmont HealthCare (D.J.), Mooresville, NC; Neurologic Clinic and Policlinic (L.K.), Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs MS Center and Pediatric MS Center of Excellence (B.W.-G.), Jacobs Neurological Institute, Buffalo, NY; Department of Neurology (H.-P.H.), Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany; and University of California San Francisco Multiple Sclerosis Center (B.A.C.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004485DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634662PMC
October 2017

Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis.

J Neuroimaging 2017 09 29;27(5):476-480. Epub 2017 Mar 29.

Multiple Sclerosis Center, Department of Neurology, Wayne State University School of Medicine, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jon.12435DOI Listing
September 2017

Acute liver injury in a Glatopa-treated patient with MS.

Neurol Neuroimmunol Neuroinflamm 2017 Jul 5;4(4):e368. Epub 2017 Jun 5.

Multiple Sclerosis Center (J.J.S., S.S.Z., B.A.C.C.), Department of Neurology, Division of Gastroenterology (N.J.M.), Department of Medicine, and GI-Hepatobiliary Pathology Service (S.K.), Department of Pathology, University of California San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000368DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459788PMC
July 2017

Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.

PLoS One 2016 28;11(4):e0154335. Epub 2016 Apr 28.

Multiple Sclerosis and Neuroinflammation Center, Department of Neurology, University of California San Francisco, San Francisco, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0154335PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849800PMC
March 2017

Onset of secondary progressive MS after long-term rituximab therapy - a case report.

Ann Clin Transl Neurol 2017 Jan 20;4(1):46-52. Epub 2016 Dec 20.

Department of Neurology Weill Institute for Neurosciences University of California San Francisco California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acn3.377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221476PMC
January 2017

Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.

Neurol Neuroimmunol Neuroinflamm 2016 Oct 21;3(5):e272. Epub 2016 Sep 21.

Department of Neurology (M.V.-D., K.L.P., C.M.S., B.A.C.C., U.S.-T., S.S.Z.) and Program in Immunology (M.V.-D., K.L.P., C.M.S., U.S.-T., S.S.Z.), University of California, San Francisco; Multiple Sclerosis Research Group (C.C.A.B.), Australian Regenerative Medicine Institute, Monash University, Clayton, Australia; and Department of Pathology (R.A.S.), Stanford University, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032667PMC
October 2016

Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens.

Ann Neurol 2016 09 4;80(3):443-7. Epub 2016 Aug 4.

Department of Neurology, University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053302PMC
September 2016

Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.

JAMA Neurol 2016 07;73(7):795-802

Department of Neurology, School of Medicine, University of California, San Francisco5Bioengineering Graduate Group, University of California, San Francisco and Berkeley6Department of Radiology and Biomedical Imaging, University of California, San Francisc.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081075PMC
http://dx.doi.org/10.1001/jamaneurol.2016.0980DOI Listing
July 2016

Steering through complexity: management approaches in multiple sclerosis.

Curr Opin Neurol 2016 06;29(3):263-71

aDepartment of Neurology, Multiple Sclerosis Center, University of California, San Francisco, California, USA bDepartment of Neurology and Center for Neuropsychiatry, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000332DOI Listing
June 2016

Statistical Considerations for an Adaptive Design for a Serious Rare Disease.

Ther Innov Regul Sci 2016 May;50(3):375-384

4 University of Alabama, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2168479015619203DOI Listing
May 2016

Characterizing retinal structure injury in African-Americans with multiple sclerosis.

Mult Scler Relat Disord 2016 May 12;7:16-20. Epub 2016 Feb 12.

Retinal Biology Program in Neurosciences and The Sastry Foundation Advanced Imaging Laboratory, United States; Multiple Sclerosis Center, Department of Neurology, Wayne State University School of Medicine, Detroit, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.02.009DOI Listing
May 2016

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.

Proc Natl Acad Sci U S A 2016 Apr 13;113(17):4777-82. Epub 2016 Apr 13.

Department of Neurology, University of California, San Francisco, CA 94143; Program in Immunology, University of California, San Francisco, CA 94143;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1603907113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855599PMC
April 2016

Placebo controlled trials in neuromyelitis optica are needed and ethical.

Authors:
Bruce A C Cree

Mult Scler Relat Disord 2015 Nov 31;4(6):536-45. Epub 2015 Jul 31.

University of California San Francisco, 675 Nelson Rising Lane, Box 3206, San Francisco, CA 94110, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2015.07.017DOI Listing
November 2015

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

JAMA Neurol 2015 Aug;72(8):897-904

Department of Neurology, University of California, San Francisco5Bioengineering Graduate Group, University of California, San Francisco and Berkeley6Department of Radiology and Biomedical Imaging, University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2015.0993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002864PMC
August 2015

Simultaneous serum aquaporin-4 antibody and CSF NMDA receptor antibody-positive encephalitis.

Neurol Neuroimmunol Neuroinflamm 2015 Jun 9;2(3):e101. Epub 2015 Apr 9.

Departments of Neurology (J.P.O., B.A.C.C.) and Pathology (M.P.), University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396527PMC
June 2015

Challenges and opportunities in designing clinical trials for neuromyelitis optica.

Neurology 2015 Apr 3;84(17):1805-15. Epub 2015 Apr 3.

From the Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN; MedImmune Ltd. (G.B., A.F.), Riverside Building, Granta Park, Great Abington, Cambridge, UK; Guthy-Jackson Foundation (J.M.B., K.V.H.), San Diego, CA; Departments of Neurology and Ophthalmology (J.L.B.), University of Colorado Denver, Aurora; Novartis Pharmaceuticals Corporation (P.S.C.), East Hanover, NJ; Department of Neurology (B.A.C.C.), University of California San Francisco; CIC (Clinical Investigation Center) INSERM and UMR 1119 (J.d.S.), INSERM, Federation de Medecine Translationelle de Strasbourg, Université de Strasbourg; Department of Multiple Sclerosis Therapeutics (K.F.), Tohoku University, Sendai, Japan; Department of Neurology (B.G.), University of Texas Southwestern; Chugai Pharma USA (S.H., A.T.M.), Berkeley Heights, NJ; PPD Inc. (W.H.), Wilmington, NC; Department of Neurology (O.K.), Wayne State University, Detroit, MI; Teva Pharmaceuticals (V.K.), Frazer, PA; Department of Neurology (V.K.), Heinrich-Heine University, Dusseldorf, Germany; Department of Neurology (M.L.), Johns Hopkins University, Baltimore, MD; Department of Neurology (J.P.), Oxford University Hospital Trust, UK; Department of Ophthalmology and Visual Sciences (T.J.S.), Kellogg Eye Center, and Division of Metabolism, Endocrine, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor; Department of Health Science (M.P.S.), University of Genoa, Italy; David Geffen School of Medicine at UCLA (K.V.H.), Los Angeles, CA; GlaxoSmithKline (S.V.), Research Triangle Park, NC; Center of Neuroimmunology (P.V.), Institute of Biomedical Research August Pi Sunyer (IDIBAPS)-Hospital Clinic Barcelona, Villarroel, Spain; United States Food and Drug Administration (M.K.W.), Center for Drug Evaluation and Research, Silver Spring, MD; Alexion Pharmaceuticals Inc. (W.W.), Cheshire, CT; Department of Neurology (D.M.W.), Mayo Clinic, Scottsdale, AZ; Department of Medicine (M.R.Y.), Divisions of M

View Article

Download full-text PDF

Source
http://www.neurology.org/content/84/17/1805.full.pdf
Web Search
http://www.neurology.org/cgi/doi/10.1212/WNL.000000000000152
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000001520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424131PMC
April 2015

Encephalitis of unclear origin diagnosed by brain biopsy: a diagnostic challenge.

JAMA Neurol 2015 Jan;72(1):66-72

Multiple Sclerosis and Neuroinflammation Center, Department of Neurology, University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2014.2376DOI Listing
January 2015

Demyelinating disease: Is TOPIC the last trial for clinically isolated syndrome?

Authors:
Bruce A C Cree

Nat Rev Neurol 2015 Jan 16;11(1):6-7. Epub 2014 Dec 16.

Multiple Sclerosis Center, 675 Nelson Rising Lane, Suite 221, Box 3206, San Francisco, CA 94158, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneurol.2014.239DOI Listing
January 2015

Transient hyperckemia in the setting of neuromyelitis optica (NMO).

Muscle Nerve 2014 Nov 24;50(5):859-62. Epub 2014 Sep 24.

UCSF, Neurology, 505 Parnassus Avenue Box 0114 M-798, San Francisco, California, USA, 94143.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.24298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306419PMC
November 2014

Spinal cord gray matter atrophy correlates with multiple sclerosis disability.

Ann Neurol 2014 Oct 21;76(4):568-80. Epub 2014 Aug 21.

Department of Neurology, University of California, San Francisco, San Francisco, CA; Department of Neurology, University Hospital Basel, University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24241DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5316412PMC
October 2014

Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.

Neurol Neuroimmunol Neuroinflamm 2014 Oct 9;1(3):e34. Epub 2014 Oct 9.

MS Center, Department of Neurology (J.M.G., B.A.C.C.) and Department of Pathology (J.C., E.J.H.), University of California, San Francisco; and Kaiser Permanente Neurology (J.K.), Walnut Creek, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204228PMC
October 2014

Multiple sclerosis genetics.

Authors:
Bruce A C Cree

Handb Clin Neurol 2014 ;122:193-209

Department of Neurology, University of California, San Francisco, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-52001-2.00009-1DOI Listing
September 2014

Genetics of primary progressive multiple sclerosis.

Authors:
Bruce A C Cree

Handb Clin Neurol 2014 ;122:211-30

Department of Neurology, University of California, San Francisco, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-52001-2.00042-XDOI Listing
September 2014

Acute inflammatory myelopathies.

Authors:
Bruce A C Cree

Handb Clin Neurol 2014 ;122:613-67

Department of Neurology, University of California, San Francisco, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/B97804445200120
Publisher Site
http://dx.doi.org/10.1016/B978-0-444-52001-2.00027-3DOI Listing
September 2014

MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.

Neurol Neuroimmunol Neuroinflamm 2014 Aug 14;1(2):e20. Epub 2014 Aug 14.

Department of Neurology and Program in Immunology (M.V.-D., A.S., C.M.S., U.S.-T., B.A.C.C., S.S.Z.), University of California, San Francisco; Department of Neuropathology and Department of Neurology (M.S.W.), University Medical Center, Georg-August University, Göttingen, Germany; Multiple Sclerosis Research Group (C.C.A.B.), Australian Regenerative Medicine Institute, Monash University, Clayton, Victoria, Australia; Department of Immunology (T.F.), University of Texas at San Antonio; and Boehringer Ingelheim (A.J.S.), Ridgefield, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202926PMC
August 2014

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.

Neurology 2014 Apr 28;82(17):1491-8. Epub 2014 Mar 28.

From the Mellen Center for Multiple Sclerosis (R.J.F.), Cleveland Clinic, OH; University of California San Francisco Multiple Sclerosis Center (B.A.C.C.); Hopital Civil (J.D.S.), Strasbourg, France; St. Josef Hospital (R.G.), Ruhr University, Bochum; Department of Neurology (H.-P.H.), Heinrich-Heine-University, Düsseldorf, Germany; The MS Center at Advance Neurology at Cornerstone Health Care (D.J.), Advance, NC; Departments of Neurology and Biomedicine (L.K.), University Hospital Basel, Switzerland; MS Center (M.K.), Carolinas Medical Center, Charlotte, NC; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs MS Center and Pediatric MS Center of Excellence (B.W.-G.), Jacobs Neurological Institute, Buffalo, NY; Infusion Communications (B.A.), Haddam, CT; and Biogen Idec Inc. (A.N., B.T., P.D.), Weston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011468PMC
April 2014

2014 multiple sclerosis therapeutic update.

Authors:
Bruce A C Cree

Neurohospitalist 2014 Apr;4(2):63-5

UCSF MS Center, Department of Neurology, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1941874414525410DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975801PMC
April 2014

Disease activity free status: a new end point for a new era in multiple sclerosis clinical research?

JAMA Neurol 2014 Mar;71(3):269-70

Multiple Sclerosis Center, University of California, San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2013.5486DOI Listing
March 2014

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

Authors:
Ashley H Beecham Nikolaos A Patsopoulos Dionysia K Xifara Mary F Davis Anu Kemppinen Chris Cotsapas Tejas S Shah Chris Spencer David Booth An Goris Annette Oturai Janna Saarela Bertrand Fontaine Bernhard Hemmer Claes Martin Frauke Zipp Sandra D'Alfonso Filippo Martinelli-Boneschi Bruce Taylor Hanne F Harbo Ingrid Kockum Jan Hillert Tomas Olsson Maria Ban Jorge R Oksenberg Rogier Hintzen Lisa F Barcellos Cristina Agliardi Lars Alfredsson Mehdi Alizadeh Carl Anderson Robert Andrews Helle Bach Søndergaard Amie Baker Gavin Band Sergio E Baranzini Nadia Barizzone Jeffrey Barrett Céline Bellenguez Laura Bergamaschi Luisa Bernardinelli Achim Berthele Viola Biberacher Thomas M C Binder Hannah Blackburn Izaura L Bomfim Paola Brambilla Simon Broadley Bruno Brochet Lou Brundin Dorothea Buck Helmut Butzkueven Stacy J Caillier William Camu Wassila Carpentier Paola Cavalla Elisabeth G Celius Irène Coman Giancarlo Comi Lucia Corrado Leentje Cosemans Isabelle Cournu-Rebeix Bruce A C Cree Daniele Cusi Vincent Damotte Gilles Defer Silvia R Delgado Panos Deloukas Alessia di Sapio Alexander T Dilthey Peter Donnelly Bénédicte Dubois Martin Duddy Sarah Edkins Irina Elovaara Federica Esposito Nikos Evangelou Barnaby Fiddes Judith Field Andre Franke Colin Freeman Irene Y Frohlich Daniela Galimberti Christian Gieger Pierre-Antoine Gourraud Christiane Graetz Andrew Graham Verena Grummel Clara Guaschino Athena Hadjixenofontos Hakon Hakonarson Christopher Halfpenny Gillian Hall Per Hall Anders Hamsten James Harley Timothy Harrower Clive Hawkins Garrett Hellenthal Charles Hillier Jeremy Hobart Muni Hoshi Sarah E Hunt Maja Jagodic Ilijas Jelčić Angela Jochim Brian Kendall Allan Kermode Trevor Kilpatrick Keijo Koivisto Ioanna Konidari Thomas Korn Helena Kronsbein Cordelia Langford Malin Larsson Mark Lathrop Christine Lebrun-Frenay Jeannette Lechner-Scott Michelle H Lee Maurizio A Leone Virpi Leppä Giuseppe Liberatore Benedicte A Lie Christina M Lill Magdalena Lindén Jenny Link Felix Luessi Jan Lycke Fabio Macciardi Satu Männistö Clara P Manrique Roland Martin Vittorio Martinelli Deborah Mason Gordon Mazibrada Cristin McCabe Inger-Lise Mero Julia Mescheriakova Loukas Moutsianas Kjell-Morten Myhr Guy Nagels Richard Nicholas Petra Nilsson Fredrik Piehl Matti Pirinen Siân E Price Hong Quach Mauri Reunanen Wim Robberecht Neil P Robertson Mariaemma Rodegher David Rog Marco Salvetti Nathalie C Schnetz-Boutaud Finn Sellebjerg Rebecca C Selter Catherine Schaefer Sandip Shaunak Ling Shen Simon Shields Volker Siffrin Mark Slee Per Soelberg Sorensen Melissa Sorosina Mireia Sospedra Anne Spurkland Amy Strange Emilie Sundqvist Vincent Thijs John Thorpe Anna Ticca Pentti Tienari Cornelia van Duijn Elizabeth M Visser Steve Vucic Helga Westerlind James S Wiley Alastair Wilkins James F Wilson Juliane Winkelmann John Zajicek Eva Zindler Jonathan L Haines Margaret A Pericak-Vance Adrian J Ivinson Graeme Stewart David Hafler Stephen L Hauser Alastair Compston Gil McVean Philip De Jager Stephen J Sawcer Jacob L McCauley

Nat Genet 2013 Nov 29;45(11):1353-60. Epub 2013 Sep 29.

1] John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA. [2].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2770DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832895PMC
November 2013

Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis.

Authors:
Bruce A C Cree

Mult Scler 2013 Jun 14;19(7):835-43. Epub 2013 Jan 14.

Department of Neurology, UCSF Medical Center, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458512471880
Publisher Site
http://dx.doi.org/10.1177/1352458512471880DOI Listing
June 2013

Acute transverse myelitis: demyelinating, inflammatory, and infectious myelopathies.

Semin Neurol 2012 Apr 8;32(2):97-113. Epub 2012 Sep 8.

Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, Nevada 89106, USA.

View Article

Download full-text PDF

Source
https://www.thieme-connect.com/products/ejournals/pdf/10.105
Web Search
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0032-1322586
Publisher Site
http://dx.doi.org/10.1055/s-0032-1322586DOI Listing
April 2012

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

Authors:
Stephen Sawcer Garrett Hellenthal Matti Pirinen Chris C A Spencer Nikolaos A Patsopoulos Loukas Moutsianas Alexander Dilthey Zhan Su Colin Freeman Sarah E Hunt Sarah Edkins Emma Gray David R Booth Simon C Potter An Goris Gavin Band Annette Bang Oturai Amy Strange Janna Saarela Céline Bellenguez Bertrand Fontaine Matthew Gillman Bernhard Hemmer Rhian Gwilliam Frauke Zipp Alagurevathi Jayakumar Roland Martin Stephen Leslie Stanley Hawkins Eleni Giannoulatou Sandra D'alfonso Hannah Blackburn Filippo Martinelli Boneschi Jennifer Liddle Hanne F Harbo Marc L Perez Anne Spurkland Matthew J Waller Marcin P Mycko Michelle Ricketts Manuel Comabella Naomi Hammond Ingrid Kockum Owen T McCann Maria Ban Pamela Whittaker Anu Kemppinen Paul Weston Clive Hawkins Sara Widaa John Zajicek Serge Dronov Neil Robertson Suzannah J Bumpstead Lisa F Barcellos Rathi Ravindrarajah Roby Abraham Lars Alfredsson Kristin Ardlie Cristin Aubin Amie Baker Katharine Baker Sergio E Baranzini Laura Bergamaschi Roberto Bergamaschi Allan Bernstein Achim Berthele Mike Boggild Jonathan P Bradfield David Brassat Simon A Broadley Dorothea Buck Helmut Butzkueven Ruggero Capra William M Carroll Paola Cavalla Elisabeth G Celius Sabine Cepok Rosetta Chiavacci Françoise Clerget-Darpoux Katleen Clysters Giancarlo Comi Mark Cossburn Isabelle Cournu-Rebeix Mathew B Cox Wendy Cozen Bruce A C Cree Anne H Cross Daniele Cusi Mark J Daly Emma Davis Paul I W de Bakker Marc Debouverie Marie Beatrice D'hooghe Katherine Dixon Rita Dobosi Bénédicte Dubois David Ellinghaus Irina Elovaara Federica Esposito Claire Fontenille Simon Foote Andre Franke Daniela Galimberti Angelo Ghezzi Joseph Glessner Refujia Gomez Olivier Gout Colin Graham Struan F A Grant Franca Rosa Guerini Hakon Hakonarson Per Hall Anders Hamsten Hans-Peter Hartung Rob N Heard Simon Heath Jeremy Hobart Muna Hoshi Carmen Infante-Duarte Gillian Ingram Wendy Ingram Talat Islam Maja Jagodic Michael Kabesch Allan G Kermode Trevor J Kilpatrick Cecilia Kim Norman Klopp Keijo Koivisto Malin Larsson Mark Lathrop Jeannette S Lechner-Scott Maurizio A Leone Virpi Leppä Ulrika Liljedahl Izaura Lima Bomfim Robin R Lincoln Jenny Link Jianjun Liu Aslaug R Lorentzen Sara Lupoli Fabio Macciardi Thomas Mack Mark Marriott Vittorio Martinelli Deborah Mason Jacob L McCauley Frank Mentch Inger-Lise Mero Tania Mihalova Xavier Montalban John Mottershead Kjell-Morten Myhr Paola Naldi William Ollier Alison Page Aarno Palotie Jean Pelletier Laura Piccio Trevor Pickersgill Fredrik Piehl Susan Pobywajlo Hong L Quach Patricia P Ramsay Mauri Reunanen Richard Reynolds John D Rioux Mariaemma Rodegher Sabine Roesner Justin P Rubio Ina-Maria Rückert Marco Salvetti Erika Salvi Adam Santaniello Catherine A Schaefer Stefan Schreiber Christian Schulze Rodney J Scott Finn Sellebjerg Krzysztof W Selmaj David Sexton Ling Shen Brigid Simms-Acuna Sheila Skidmore Patrick M A Sleiman Cathrine Smestad Per Soelberg Sørensen Helle Bach Søndergaard Jim Stankovich Richard C Strange Anna-Maija Sulonen Emilie Sundqvist Ann-Christine Syvänen Francesca Taddeo Bruce Taylor Jenefer M Blackwell Pentti Tienari Elvira Bramon Ayman Tourbah Matthew A Brown Ewa Tronczynska Juan P Casas Niall Tubridy Aiden Corvin Jane Vickery Janusz Jankowski Pablo Villoslada Hugh S Markus Kai Wang Christopher G Mathew James Wason Colin N A Palmer H-Erich Wichmann Robert Plomin Ernest Willoughby Anna Rautanen Juliane Winkelmann Michael Wittig Richard C Trembath Jacqueline Yaouanq Ananth C Viswanathan Haitao Zhang Nicholas W Wood Rebecca Zuvich Panos Deloukas Cordelia Langford Audrey Duncanson Jorge R Oksenberg Margaret A Pericak-Vance Jonathan L Haines Tomas Olsson Jan Hillert Adrian J Ivinson Philip L De Jager Leena Peltonen Graeme J Stewart David A Hafler Stephen L Hauser Gil McVean Peter Donnelly Alastair Compston

Nature 2011 Aug 10;476(7359):214-9. Epub 2011 Aug 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature10251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182531PMC
August 2011

Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels.

J Clin Neurosci 2011 Jul 11;18(7):997-8. Epub 2011 May 11.

Department of Neurology, Tohoku University School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2010.12.011DOI Listing
July 2011

Neuromyelitis optica, psychiatric symptoms and primary polydipsia: a case report.

Gen Hosp Psychiatry 2010 Nov-Dec;32(6):648.e5-8

Department of Psychiatry, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.genhosppsych.2010.07.009DOI Listing
April 2011

Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data.

Arch Neurol 2011 Apr;68(4):464-8

UCSF Multiple Sclerosis Center, Department of Neurology, University of California, San Francisco, 94117, USA.

View Article

Download full-text PDF

Source
http://archneur.jamanetwork.com/article.aspx?doi=10.1001/arc
Publisher Site
http://dx.doi.org/10.1001/archneurol.2011.45DOI Listing
April 2011

Diagnosis and differential diagnosis of multiple sclerosis.

Authors:
Bruce A C Cree

Continuum (Minneap Minn) 2010 Oct;16(5 Multiple Sclerosis):19-36

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00132979-201010000-000
Publisher Site
http://dx.doi.org/10.1212/01.CON.0000389932.38919.c7DOI Listing
October 2010

Natalizumab dosage suspension: are we helping or hurting?

Ann Neurol 2010 Sep;68(3):395-9

Multiple Sclerosis Center, University of California at San Francisco, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.22163
Publisher Site
http://dx.doi.org/10.1002/ana.22163DOI Listing
September 2010

Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.

Ann Neurol 2010 Aug;68(2):145-50

Multiple Sclerosis Center at University of California, San Francisco, 94117, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ana.22006
Publisher Site
http://dx.doi.org/10.1002/ana.22006DOI Listing
August 2010

Response to interferon beta-1a treatment in African American multiple sclerosis patients.

Arch Neurol 2005 Nov;62(11):1681-3

Multiple Sclerosis Center, University of California, San Francisco, 94117, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archneur.62.11.1681DOI Listing
November 2005

Neuromyelitis optica.

Semin Neurol 2002 Jun;22(2):105-22

Department of Neurology, University of California San Francisco, USA.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-2002-36534
Publisher Site
http://dx.doi.org/10.1055/s-2002-36534DOI Listing
June 2002